chr19-11041385-A-G
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting
The NM_001387283.1(SMARCA4):āc.4345A>Gā(p.Ser1449Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000434 in 1,612,612 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S1449R) has been classified as Uncertain significance.
Frequency
Consequence
NM_001387283.1 missense
Scores
Clinical Significance
Conservation
Publications
- Coffin-Siris syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet, Illumina
- intellectual disability, autosomal dominant 16Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
- rhabdoid tumor predisposition syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
- uterine corpus sarcomaInheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
- familial rhabdoid tumorInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hereditary nonpolyposis colon cancerInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SMARCA4 | NM_001387283.1 | c.4345A>G | p.Ser1449Gly | missense_variant | Exon 31 of 36 | ENST00000646693.2 | NP_001374212.1 | |
SMARCA4 | NM_003072.5 | c.4249A>G | p.Ser1417Gly | missense_variant | Exon 30 of 35 | ENST00000344626.10 | NP_003063.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SMARCA4 | ENST00000646693.2 | c.4345A>G | p.Ser1449Gly | missense_variant | Exon 31 of 36 | NM_001387283.1 | ENSP00000495368.1 | |||
SMARCA4 | ENST00000344626.10 | c.4249A>G | p.Ser1417Gly | missense_variant | Exon 30 of 35 | 1 | NM_003072.5 | ENSP00000343896.4 | ||
SMARCA4 | ENST00000643549.1 | c.4255A>G | p.Ser1419Gly | missense_variant | Exon 30 of 35 | ENSP00000493975.1 | ||||
SMARCA4 | ENST00000541122.6 | c.4159A>G | p.Ser1387Gly | missense_variant | Exon 30 of 35 | 5 | ENSP00000445036.2 | |||
SMARCA4 | ENST00000643296.1 | c.4159A>G | p.Ser1387Gly | missense_variant | Exon 29 of 34 | ENSP00000496635.1 | ||||
SMARCA4 | ENST00000644737.1 | c.4159A>G | p.Ser1387Gly | missense_variant | Exon 29 of 34 | ENSP00000495548.1 | ||||
SMARCA4 | ENST00000589677.5 | c.4159A>G | p.Ser1387Gly | missense_variant | Exon 30 of 35 | 5 | ENSP00000464778.1 | |||
SMARCA4 | ENST00000643995.1 | c.3670A>G | p.Ser1224Gly | missense_variant | Exon 27 of 32 | ENSP00000496004.1 | ||||
SMARCA4 | ENST00000644963.1 | c.2902A>G | p.Ser968Gly | missense_variant | Exon 23 of 28 | ENSP00000495599.1 | ||||
SMARCA4 | ENST00000644065.1 | c.2884A>G | p.Ser962Gly | missense_variant | Exon 22 of 27 | ENSP00000493615.1 | ||||
SMARCA4 | ENST00000642350.1 | c.2743A>G | p.Ser915Gly | missense_variant | Exon 22 of 27 | ENSP00000495355.1 | ||||
SMARCA4 | ENST00000643857.1 | c.2611A>G | p.Ser871Gly | missense_variant | Exon 21 of 25 | ENSP00000494159.1 | ||||
SMARCA4 | ENST00000538456.4 | c.415A>G | p.Ser139Gly | missense_variant | Exon 4 of 8 | 3 | ENSP00000495197.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152220Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000403 AC: 1AN: 248168 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1460392Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 726574 show subpopulations ā ļø The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152220Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74372 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Rhabdoid tumor predisposition syndrome 2 Uncertain:2
This sequence change replaces serine, which is neutral and polar, with glycine, which is neutral and non-polar, at codon 1449 of the SMARCA4 protein (p.Ser1449Gly). This variant is present in population databases (rs373390083, gnomAD 0.007%). This variant has not been reported in the literature in individuals affected with SMARCA4-related conditions. ClinVar contains an entry for this variant (Variation ID: 470394). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt SMARCA4 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
- -
Hereditary cancer-predisposing syndrome Uncertain:1Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
- -
Intellectual disability, autosomal dominant 16 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at